Review
Cell Biology
Shuangyu Lv, Xiaotian Li, Shizhen Zhao, Huiyang Liu, Honggang Wang
Summary: Ischemia/reperfusion (I/R) injury refers to the changes in functional and structural changes during blood flow recovery after ischemia. Myocardial I/R injury, aggravated by sudden blood circulation disorder, is still not fully understood despite numerous studies. Hydrogen sulfide (H2S) has shown potential in improving myocardial I/R injury, but the underlying signal pathways remain unclear, warranting further research.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Yikun Wu, Hua Shi, Yuangao Xu, Rao Wen, Maodi Gong, Guangyi Hong, Shuxiong Xu
Summary: The present study investigated the effects of selenoproteins on renal ischemia-reperfusion (I/R) injury. The results showed that the expression of selenoprotein genes was altered in renal I/R injury, and treatment with ebselen reversed these changes and alleviated renal dysfunction, oxidative stress, and apoptosis.
BIOLOGICAL TRACE ELEMENT RESEARCH
(2023)
Article
Cardiac & Cardiovascular Systems
Liang Wang, Xuebai Lv, Jue Tian, Xiaoliang Wang, Ye Wu, Hui Rong Liu
Summary: The study found that Nec-1 may reduce myocardial cell death and maintain myocardial architectural integrity, thus inhibiting the reactive fibrosis process in rats during myocardial ischemia/late reperfusion. Administration of Nec-1 at the onset of reperfusion significantly reduced the release of creatine kinase and downregulated autophagy within 24 hours after reperfusion, with a significantly positive correlation between them.
CARDIOVASCULAR THERAPEUTICS
(2021)
Article
Environmental Sciences
Ying Liu, Yun Liu, Hong-Li Zhang, Fen-Fang Yu, Xiao-Rui Yin, Yan-Fang Zhao, Fei Ye, Xiang-Qi Wu
Summary: The study aimed to evaluate the cardioprotective effect of neoandrographolide on myocardial ischemia/reperfusion injury (I/R) models and found that Neo could alleviate myocardial I/R-induced damage by inhibiting inflammation and cell apoptosis.
ENVIRONMENTAL TOXICOLOGY
(2021)
Article
Immunology
Qihong Wu, Rong Xu, Kun Zhang, Ran Sun, Mengxi Yang, Kuan Li, Hanrui Liu, Yiyuan Xue, Huayan Xu, Yingkun Guo
Summary: This study comprehensively characterized the physiopathologic changes of myocardial injury after ischemia-reperfusion. It found that the early stage of reperfusion injury is mainly characterized by edema rather than inflammation, and suggested that edema may be a crucial factor contributing to myocardial injury.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Pharmacology & Pharmacy
Kai-yu Huang, Yong-wei Yu, Shuai Liu, Ying-ying Zhou, Jin-sheng Wang, Yang-pei Peng, Kang-ting Ji, Yang-jing Xue
Summary: The research shows that ASIV can alleviate myocardial I/R injury by regulating autophagy, and O-2(center dot-) plays a vital role in this process.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Pharmacology & Pharmacy
Chin-Feng Tsai, Hsing-Hui Su, Ke-Min Chen, Jiuan-Miaw Liao, Yi-Ting Yao, Yi-Hung Chen, Meilin Wang, Ya-Chun Chu, Yi-Hsin Wang, Shiang-Suo Huang
Summary: Paeonol has cardioprotective effects by regulating the crosstalk between apoptosis and autophagy, inhibiting apoptotic and autophagic cell death induced by myocardial ischemia/reperfusion injury.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Medicine, Research & Experimental
Yingying Liu, Yanzhen Tan, Guojie Cao, Lei Shi, Yujie Song, Wenju Shan, Miao Zhang, Panpan Li, Haitao Zhou, Bing Zhang, Yang Sun, Wei Yi
Summary: This study demonstrates that bergenin attenuates myocardial apoptosis and oxidative damage induced by MI/R through the SIRT1 signaling pathway. Bergenin significantly reduces cardiomyocyte apoptosis and ROS production, and improves cardiac function in vitro and in vivo.
BIOMEDICINE & PHARMACOTHERAPY
(2023)
Article
Biochemistry & Molecular Biology
Yan Li, Qing Meng, Ling Wang, Yongjian Cui
Summary: The study revealed that TRIM27 plays a critical role in myocardial ischemia/reperfusion, and its deletion accelerates infarction size and cardiac dysfunction while exacerbating apoptosis and inflammatory response. The interaction between TRIM27 and p53 may be involved in regulating the physiological state of cardiomyocytes in response to ischemic injury.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(2021)
Article
Pharmacology & Pharmacy
Wen Jiang, Yuxiang Zhang, Wei Zhang, Xiaomei Pan, Jieyu Liu, Qiang Chen, Junhui Chen
Summary: Acute myocardial infarction (AMI) is the leading cause of death worldwide. Ischemia-reperfusion (I/R) injury is a common contributor to AMI. Hirsutine has been shown to protect cardiomyocytes against hypoxic injury. In this study, hirsutine pre-treatment improved myocardial I/R injury by reducing infarct size, enhancing cardiac function, inhibiting cell apoptosis, and balancing mitochondrial dynamics. Mechanistically, hirsutine inhibited mitochondrial-mediated apoptosis by blocking the AKT/ASK-1/p38 MAPK pathway. This study provides a promising therapeutic intervention for myocardial I/R injury.
CLINICAL AND EXPERIMENTAL HYPERTENSION
(2023)
Article
Cardiac & Cardiovascular Systems
Chantal Eickelmann, Helmut Raphael Lieder, Sharaf-Eldin Shehada, Matthias Thielmann, Gerd Heusch, Petra Kleinbongard
Summary: Mitochondrial function is critical for myocardial ischemia-reperfusion injury and cardioprotection. Measuring mitochondrial function in permeabilized cardiac tissue can reflect mitochondrial dysfunction following ischemia-reperfusion.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
(2023)
Article
Engineering, Biomedical
Wenqiang Qian, Daozhou Liu, Ying Han, Miao Liu, Bao Liu, Qifeng Ji, Bangle Zhang, Qibing Mei, Siyuan Zhou, Ying Cheng
Summary: Simultaneous inhibition of ferroptosis and apoptosis of cardiomyocytes can be a promising strategy to treat myocardial ischemia-reperfusion injury (MI/RI). Taking advantage of the highly expressed transferrin receptor in ischemic myocardium, cyclosporin A (CsA) was wrapped with apoferritin (ApoFn) to actively target and inhibit both ferroptosis and apoptosis in MI/RI mice, resulting in the restoration of cardiac function.
ACTA BIOMATERIALIA
(2023)
Review
Pharmacology & Pharmacy
Zhihan Chen, Jingping Wu, Sijing Li, Caijiao Liu, Yulan Ren
Summary: Ischemic heart disease is a fatal condition, and reperfusion is the recommended therapy. However, restoring blood flow to ischemic tissue can cause myocardial ischemia/reperfusion injury (MIRI). Apoptosis is a crucial factor in MIRI, and ginsenosides have shown effectiveness in inhibiting apoptosis and alleviating MIRI. In this review, we examined published studies on the anti-apoptotic effects of ginsenosides and their mechanisms of action in improving MIRI.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Pharmacology & Pharmacy
Enhui Yao, Lili Luo, Chenxi Lin, Jing Wen, Yanglongfei Li, Tong Ren, Yujie Chen, Jinhua Huang, Xin Jin
Summary: This study found that oleoylethanolamide (OEA) can alleviate myocardial cell apoptosis in diabetic rats with myocardial ischemia-reperfusion injury (MIRI) by activating the PI3K/Akt signaling pathway. These findings provide a theoretical basis for the use of OEA as a potential therapeutic agent for MIRI in diabetic patients.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Cell Biology
Ke Peng, Hong Liu, Bin Yan, Xiao-Wen Meng, Shao-Yong Song, Fu-Hai Ji, Zhengyuan Xia
Summary: This study identified and validated key candidate genes related to inflammation and apoptosis pathways underlying myocardial I/R injury. Inhibition of Cathepsin S was shown to alleviate myocardial I/R-induced injury by suppressing inflammation and apoptosis, potentially offering clinical applications in cardioprotection.
JOURNAL OF CELLULAR PHYSIOLOGY
(2021)